ISRCTN32042139已完成不适用
Dose-ranging study of SCH34117 in the treatment of patients with seasonal allergic rhinitis
Schering-Plough Research Institute (SPRI) (USA)0 个研究点目标入组 1,026 人开始时间: 2002年8月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,026
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects 12 years or older with a two-year documented history of seasonal allergic rhinitis and otherwise in good health
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPDCOPDMedDRA version: 9.1 Level: LLT Classification code 10009033 Term: Chronic obstructive pulmonary diseaseEUCTR2008-003780-38-FRSchering-Plough Research Institute500
招募中
2 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)ACTRN12610000345088Schering-Plough500
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD - NDCOPDMedDRA version: 9.1 Level: PT Classification code 10009033EUCTR2008-003780-38-ITSchering Plough Research Institute500
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPDCOPDMedDRA version: 9.1 Level: LLT Classification code 10009033 Term: Chronic obstructive pulmonary diseaseEUCTR2008-003780-38-GRSchering-Plough Research Institute500
未知
2 期
Dose-response study of SM-13496 in patients with schizophrenia [late Phase 2 study]SchizophreniaJPRN-jRCT2080220090Dainippon Sumitomo Pharma Co., Ltd.